Drug makers in 31 foreign countries, including China, Russia and Belarus, paid hundreds of millions of dollars in royalties to top officials at the National Institutes of Health (NIH).
You might have thought that everything about "Proximal Origin" had been said—and that’s certainly what we thought—but now there is a new and shocking twist.